[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
December 2002

Mycophenolate Mofetil for the Treatment of Cutaneous Lupus Erythematosus With Smoldering Systemic Involvement

Author Affiliations

Not Available

Arch Dermatol. 2002;138(12):1616. doi:10.1001/archderm.138.12.1613

Mycophenolate mofetil has been successfully used for the treatment of several autoimmune and inflammatory skin diseases.1 Although multiple studies support the use of mycophenolate mofetil in systemic lupus erythematosus (LE), only 3 cases describing its use in chronic cutaneous LE without systemic involvement have been reported.2,3 We discuss the role of mycophenolate mofetil in the management of multiple variants of cutaneous LE with associated systemic disease (Table 1).

First Page Preview View Large
First page PDF preview
First page PDF preview
×